1989
DOI: 10.1210/endo-125-2-898
|View full text |Cite
|
Sign up to set email alerts
|

Synthetic Peptide Segments of Inhibin α- and β-Subunits: Preparation and Characterization of Polyclonal Antibodies*

Abstract: The amino acid sequences of human inhibin alpha-, beta A- and beta B-subunits were analyzed for hydrophilicity and chain flexibility to predict regions that are on the surface of the subunits and, therefore, are potential antigenic sites. Based on these analyses, a total of nine peptides were synthesized, and rabbit antisera against the peptides were prepared. Peptides of the N-terminus (residues 1-16 and 13-24) and region 109-123 of the alpha-subunit produced high titer antibodies. Regions 69-79 and 93-105 of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

1991
1991
2006
2006

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(4 citation statements)
references
References 32 publications
0
4
0
Order By: Relevance
“…Alternatively, it is possible that the clone E4 may have been selected for during hybridoma screening because the immobilized ß 82-114 peptide and/or native inhibin used to screen culture supernatants had oxidized spontaneously during the prep¬ aration and/or storage of antigen-coated plates. Several other groups (Saito et al 1989, Vaughan & Vale 1993 have reported the use of antibodies against C-terminal peptide sequences of inhibin ß subunit and it would be of interest to determine whether these antibodies also have a greater affinity for the oxidized antigen. If this was the case with the ßA81-113 antibody used by Vaughan & Vale (1993), it could account for the inability of their two-site IRMA to detect dimeric inhibin in crude human and porcine FF.…”
Section: Discussionmentioning
confidence: 99%
“…Alternatively, it is possible that the clone E4 may have been selected for during hybridoma screening because the immobilized ß 82-114 peptide and/or native inhibin used to screen culture supernatants had oxidized spontaneously during the prep¬ aration and/or storage of antigen-coated plates. Several other groups (Saito et al 1989, Vaughan & Vale 1993 have reported the use of antibodies against C-terminal peptide sequences of inhibin ß subunit and it would be of interest to determine whether these antibodies also have a greater affinity for the oxidized antigen. If this was the case with the ßA81-113 antibody used by Vaughan & Vale (1993), it could account for the inability of their two-site IRMA to detect dimeric inhibin in crude human and porcine FF.…”
Section: Discussionmentioning
confidence: 99%
“…The hCG-treated cells expressed at least 11 additional polypeptides and four polypeptides decreased as the result of this treatment. By immunoprecipitation it was further determined that hCG stimulated the synthesis of a 14 kDa product corresponding to a and Ob inhibin subunits, respectively [32].…”
Section: Discussionmentioning
confidence: 99%
“…Samples containing equal amounts of trichloroacetic acid-precipitable radioactivity and approximately 50 pg of protein were diluted 1:lO with NET buffer (150 mM NaCl, 5 mM EDTA; 50 mM Tris-HC1, pH 7.5, containing 1.5% Nonidet P-40 and 2.5% mg/mL bovine serum albumin). After mixing, 2 pL of either undiluted rabbit anti-inhibin a or anti-inhibin fib antisera [32] were added; the mixture was incubated for 2 h at 4"C, then 30 pL of a 50% suspension of protein A-Sepharose were added; the samples were incubated for an additional 30 min at 4°C with rotation. The samples were then centrifuged at 12000 g, at 4"C, resuspended twice with brief sonication in NET buffer containing 0.1 O/ o Nonidet P-40, and pelleted as above.…”
Section: Lmmunoprecipitationmentioning
confidence: 99%
“…Most studies in which antibodies against TGF-β superfamily cytokines have been characterized have utilized antipeptide antibodies (5,13,(18)(19)(20)(21)(22)(23)(24), although some anti-protein monoclonal antibodies (MAbs) have also been described (25)(26)(27). The majority of the above reports have concentrated on determining the ability of the antiserum to neutralize biological activity of a particular cytokine or the suitability of the antiserum for use in cytokine-specific assays.…”
mentioning
confidence: 99%